Epsilon Healthcare Limited (ASX:EPN)

Market Cap	8.17M +18.3%
Revenue (ttm)	9.39M +67.7%
Net Income	-1.28M
EPS	-0.00
Shares Out	389.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,120
Average Volume	191,669
Open	0.0210
Previous Close	0.0210
Day's Range	0.0210 - 0.0210
52-Week Range	0.0210 - 0.0400
Beta	0.73
RSI	37.40
Earnings Date	May 29, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group L...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPN

Financial Performance

In 2025, Epsilon Healthcare's revenue was 9.39 million, an increase of 67.74% compared to the previous year's 5.60 million. Losses were -1.28 million, -76.73% less than in 2024.